Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling

Qian Li, Nicole R. Sullivan, Carrie E. McAllister, Louis D. Van de Kar, Nancy A. Muma

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A major problem with current anti-depressant therapy is that it takes on average 6-7 weeks for remission. Since desensitization of serotonin (5-HT)1A receptor signaling contributes to the anti-depressive response, acceleration of the desensitization may reduce this delay in response to antidepressants. The purpose of the present study was to test the hypothesis that estradiol accelerates fluoxetine-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus (PVN) of rats, via alterations in components of the 5-HT1A receptor signaling pathway. Ovariectomized rats were injected with estradiol and/or fluoxetine, then adrenocorticotropic hormone (ACTH) and oxytocin responses to a 5-HT1A receptor agonist (+)-8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) were examined to assess the function of 5-HT1A receptors in the PVN. Treatment with estradiol for either 2 or 7 days or fluoxetine for 2 days produced at most a partial desensitization of 5-HT1A receptor signaling, whereas 7 days of fluoxetine produced full desensitization. Combined treatment with estradiol and fluoxetine for 2 days produced nearly a full desensitization, demonstrating an accelerated response compared to either treatment alone. With two days of combined treatments, estradiol prevented the fluoxetine-induced increase in 5-HT1A receptor protein, which could contribute to the more rapid desensitization. Furthermore, EB treatment for 2 days decreased the abundance of the 35kD Gαz protein which could contribute to the desensitization response. We found two isoforms of Gαz proteins with molecular mass of 35 and 33kD, which differentially distributed in the detergent resistant microdomain (DRM) and in Triton X-100 soluble membrane region, respectively. The 35kD Gαz proteins in the DRM can be sumoylated by SUMO1. Stimulation of 5-HT1A receptors with 8-OH-DPAT increases the sumoylation of Gαz proteins and reduces the 33kD Gαz proteins, suggesting that these responses may be related to the desensitization of 5-HT1A receptors. Treatment with estradiol for 2 days also reduced the levels of the G-protein coupled estrogen receptor GPR30, possibly limiting to the ability of estradiol to produce only a partial desensitization response. These data provide evidence that estradiol may be effective as a short-term adjuvant to SSRIs to accelerate the onset of therapeutic effects.

Original languageEnglish (US)
Pages (from-to)1145-1157
Number of pages13
JournalPsychoneuroendocrinology
Volume38
Issue number7
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT1A
Fluoxetine
Estradiol
8-Hydroxy-2-(di-n-propylamino)tetralin
Paraventricular Hypothalamic Nucleus
Proteins
Detergents
Hypothalamus
Sumoylation
Serotonin 5-HT1 Receptor Agonists
Octoxynol
Therapeutic Uses
Oxytocin
G-Protein-Coupled Receptors
Estrogen Receptors
Adrenocorticotropic Hormone
Antidepressive Agents
Serotonin
Protein Isoforms
Membranes

Keywords

  • 5-HT receptors
  • ACTH
  • Detergent resistant microdomain
  • Gαz
  • GPR30
  • Lipid raft
  • Oxytocin
  • SSRIs
  • Sumoylation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems

Cite this

Li, Q., Sullivan, N. R., McAllister, C. E., Van de Kar, L. D., & Muma, N. A. (2013). Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling. Psychoneuroendocrinology, 38(7), 1145-1157. https://doi.org/10.1016/j.psyneuen.2012.11.005

Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling. / Li, Qian; Sullivan, Nicole R.; McAllister, Carrie E.; Van de Kar, Louis D.; Muma, Nancy A.

In: Psychoneuroendocrinology, Vol. 38, No. 7, 07.2013, p. 1145-1157.

Research output: Contribution to journalArticle

Li, Q, Sullivan, NR, McAllister, CE, Van de Kar, LD & Muma, NA 2013, 'Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling', Psychoneuroendocrinology, vol. 38, no. 7, pp. 1145-1157. https://doi.org/10.1016/j.psyneuen.2012.11.005
Li, Qian ; Sullivan, Nicole R. ; McAllister, Carrie E. ; Van de Kar, Louis D. ; Muma, Nancy A. / Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling. In: Psychoneuroendocrinology. 2013 ; Vol. 38, No. 7. pp. 1145-1157.
@article{f0133764279448bebef99499de7fbeae,
title = "Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling",
abstract = "A major problem with current anti-depressant therapy is that it takes on average 6-7 weeks for remission. Since desensitization of serotonin (5-HT)1A receptor signaling contributes to the anti-depressive response, acceleration of the desensitization may reduce this delay in response to antidepressants. The purpose of the present study was to test the hypothesis that estradiol accelerates fluoxetine-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus (PVN) of rats, via alterations in components of the 5-HT1A receptor signaling pathway. Ovariectomized rats were injected with estradiol and/or fluoxetine, then adrenocorticotropic hormone (ACTH) and oxytocin responses to a 5-HT1A receptor agonist (+)-8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) were examined to assess the function of 5-HT1A receptors in the PVN. Treatment with estradiol for either 2 or 7 days or fluoxetine for 2 days produced at most a partial desensitization of 5-HT1A receptor signaling, whereas 7 days of fluoxetine produced full desensitization. Combined treatment with estradiol and fluoxetine for 2 days produced nearly a full desensitization, demonstrating an accelerated response compared to either treatment alone. With two days of combined treatments, estradiol prevented the fluoxetine-induced increase in 5-HT1A receptor protein, which could contribute to the more rapid desensitization. Furthermore, EB treatment for 2 days decreased the abundance of the 35kD Gαz protein which could contribute to the desensitization response. We found two isoforms of Gαz proteins with molecular mass of 35 and 33kD, which differentially distributed in the detergent resistant microdomain (DRM) and in Triton X-100 soluble membrane region, respectively. The 35kD Gαz proteins in the DRM can be sumoylated by SUMO1. Stimulation of 5-HT1A receptors with 8-OH-DPAT increases the sumoylation of Gαz proteins and reduces the 33kD Gαz proteins, suggesting that these responses may be related to the desensitization of 5-HT1A receptors. Treatment with estradiol for 2 days also reduced the levels of the G-protein coupled estrogen receptor GPR30, possibly limiting to the ability of estradiol to produce only a partial desensitization response. These data provide evidence that estradiol may be effective as a short-term adjuvant to SSRIs to accelerate the onset of therapeutic effects.",
keywords = "5-HT receptors, ACTH, Detergent resistant microdomain, Gαz, GPR30, Lipid raft, Oxytocin, SSRIs, Sumoylation",
author = "Qian Li and Sullivan, {Nicole R.} and McAllister, {Carrie E.} and {Van de Kar}, {Louis D.} and Muma, {Nancy A.}",
year = "2013",
month = "7",
doi = "10.1016/j.psyneuen.2012.11.005",
language = "English (US)",
volume = "38",
pages = "1145--1157",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling

AU - Li, Qian

AU - Sullivan, Nicole R.

AU - McAllister, Carrie E.

AU - Van de Kar, Louis D.

AU - Muma, Nancy A.

PY - 2013/7

Y1 - 2013/7

N2 - A major problem with current anti-depressant therapy is that it takes on average 6-7 weeks for remission. Since desensitization of serotonin (5-HT)1A receptor signaling contributes to the anti-depressive response, acceleration of the desensitization may reduce this delay in response to antidepressants. The purpose of the present study was to test the hypothesis that estradiol accelerates fluoxetine-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus (PVN) of rats, via alterations in components of the 5-HT1A receptor signaling pathway. Ovariectomized rats were injected with estradiol and/or fluoxetine, then adrenocorticotropic hormone (ACTH) and oxytocin responses to a 5-HT1A receptor agonist (+)-8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) were examined to assess the function of 5-HT1A receptors in the PVN. Treatment with estradiol for either 2 or 7 days or fluoxetine for 2 days produced at most a partial desensitization of 5-HT1A receptor signaling, whereas 7 days of fluoxetine produced full desensitization. Combined treatment with estradiol and fluoxetine for 2 days produced nearly a full desensitization, demonstrating an accelerated response compared to either treatment alone. With two days of combined treatments, estradiol prevented the fluoxetine-induced increase in 5-HT1A receptor protein, which could contribute to the more rapid desensitization. Furthermore, EB treatment for 2 days decreased the abundance of the 35kD Gαz protein which could contribute to the desensitization response. We found two isoforms of Gαz proteins with molecular mass of 35 and 33kD, which differentially distributed in the detergent resistant microdomain (DRM) and in Triton X-100 soluble membrane region, respectively. The 35kD Gαz proteins in the DRM can be sumoylated by SUMO1. Stimulation of 5-HT1A receptors with 8-OH-DPAT increases the sumoylation of Gαz proteins and reduces the 33kD Gαz proteins, suggesting that these responses may be related to the desensitization of 5-HT1A receptors. Treatment with estradiol for 2 days also reduced the levels of the G-protein coupled estrogen receptor GPR30, possibly limiting to the ability of estradiol to produce only a partial desensitization response. These data provide evidence that estradiol may be effective as a short-term adjuvant to SSRIs to accelerate the onset of therapeutic effects.

AB - A major problem with current anti-depressant therapy is that it takes on average 6-7 weeks for remission. Since desensitization of serotonin (5-HT)1A receptor signaling contributes to the anti-depressive response, acceleration of the desensitization may reduce this delay in response to antidepressants. The purpose of the present study was to test the hypothesis that estradiol accelerates fluoxetine-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus (PVN) of rats, via alterations in components of the 5-HT1A receptor signaling pathway. Ovariectomized rats were injected with estradiol and/or fluoxetine, then adrenocorticotropic hormone (ACTH) and oxytocin responses to a 5-HT1A receptor agonist (+)-8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) were examined to assess the function of 5-HT1A receptors in the PVN. Treatment with estradiol for either 2 or 7 days or fluoxetine for 2 days produced at most a partial desensitization of 5-HT1A receptor signaling, whereas 7 days of fluoxetine produced full desensitization. Combined treatment with estradiol and fluoxetine for 2 days produced nearly a full desensitization, demonstrating an accelerated response compared to either treatment alone. With two days of combined treatments, estradiol prevented the fluoxetine-induced increase in 5-HT1A receptor protein, which could contribute to the more rapid desensitization. Furthermore, EB treatment for 2 days decreased the abundance of the 35kD Gαz protein which could contribute to the desensitization response. We found two isoforms of Gαz proteins with molecular mass of 35 and 33kD, which differentially distributed in the detergent resistant microdomain (DRM) and in Triton X-100 soluble membrane region, respectively. The 35kD Gαz proteins in the DRM can be sumoylated by SUMO1. Stimulation of 5-HT1A receptors with 8-OH-DPAT increases the sumoylation of Gαz proteins and reduces the 33kD Gαz proteins, suggesting that these responses may be related to the desensitization of 5-HT1A receptors. Treatment with estradiol for 2 days also reduced the levels of the G-protein coupled estrogen receptor GPR30, possibly limiting to the ability of estradiol to produce only a partial desensitization response. These data provide evidence that estradiol may be effective as a short-term adjuvant to SSRIs to accelerate the onset of therapeutic effects.

KW - 5-HT receptors

KW - ACTH

KW - Detergent resistant microdomain

KW - Gαz

KW - GPR30

KW - Lipid raft

KW - Oxytocin

KW - SSRIs

KW - Sumoylation

UR - http://www.scopus.com/inward/record.url?scp=84877924636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877924636&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2012.11.005

DO - 10.1016/j.psyneuen.2012.11.005

M3 - Article

VL - 38

SP - 1145

EP - 1157

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 7

ER -